2018年新版《肺血栓栓塞症诊治与预防指南》的解读与思考——以循证医学指南指导临床实践

Interpretation and thinking of the guideline for the diagnosis and treatment and prevention of pulmonary thromboembolism(the 2018 new edition)——Guide clinical practice with the evidence-based medicine guideline

肺血栓栓塞症(pulmonary thromboembolism,PTE)具有高发病率、高病死率和高致残率的特点,是严重威胁人类健康的重大医疗问题。近年来PTE领域相关研究发展迅速,已有的指南不能完全满足中国临床医师的诊治需要。鉴此,为更好地指导我国医师的临床实践,中华医学会呼吸病学分会肺栓塞与肺血管病学组、中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会基于当前的循证医学证据,制订了《肺血栓栓塞症诊治与预防指南》。该文将对新版指南进行详尽解读。

Pulmonary thromboembolism(PTE) is characterized by high incidence,high mortality and high disability rates.It is a major medical problem that seriously threatens human health.In recent years,related researches in the field of PTE have developed rapidly,and the existing guidelines are unable to fully meet the clinical needs of Chinese clinicians,based on which the guideline for the diagnosis and treatment and prevention of pulmonary thromboembolism is developed by Pulmonary Embolism and Pulmonary Vascular Diseases Group of Chinese Thoracic Society and Pulmonary Embolism and Pulmonary Vascular Disease Working Committee of Chinese Association of Chest Physicians to better guide the clinical practice of Chinese physicians.In this paper,we provide a detailed interpretation of the guideline for the diagnosis and treatment and prevention of pulmonary thromboembolism(the 2018 new edition).